Orchestra BioMed Inc.

AI Score

0

Unlock

4.12
-0.57 (-12.15%)
At close: Mar 03, 2025, 3:59 PM
4.10
-0.49%
After-hours: Mar 03, 2025, 04:00 PM EST

Orchestra BioMed Income Statement

Year FY23 FY22 FY21 FY20
Revenue 2.76M 3.53M -782K 5.7M
Cost of Revenue 186K 322K 199K 145K
Gross Profit 2.57M 3.21M -981K 5.56M
Operating Income -51.51M -32.66M -21.8M -18.75M
Interest Income 3.85M 50K 927K 331K
Pretax Income -49.12M -33.61M -23.01M -21.36M
Net Income -49.12M -33.61M -23.01M -21.36M
Selling & General & Admin 20.26M 13.92M 7.93M 10.83M
Research & Development 33.82M 21.95M 12.89M 13.48M
Other Expenses n/a n/a n/a n/a
Operating Expenses 54.08M 35.87M 20.82M 24.31M
Interest Expense n/a n/a 927K n/a
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 54.27M 36.19M 21.02M 24.45M
Income Tax n/a -222K 927K 2.6M
Shares Outstanding (Basic) 33.23M 14.99M 20.45M 20.45M
Shares Outstanding (Diluted) 33.23M 14.99M 20.45M 20.45M
EPS (Basic) -1.48 -2.24 -1.13 -1.04
EPS (Diluted) -1.48 -2.24 -1.13 -1.04
EBITDA -51.22M -32.44M -21.62M -18.61M
Depreciation & Amortization 287K 222K 181K 137K